Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Equity Ratio (2020 - 2026)

Core Scientific has reported Equity Ratio over the past 7 years, most recently at 0.43 for Q1 2026.

  • Quarterly results put Equity Ratio at 0.43 for Q1 2026, down 106.34% from a year ago — trailing twelve months through Mar 2026 was 0.43 (down 106.34% YoY), and the annual figure for FY2025 was 0.41, up 35.82%.
  • Equity Ratio reached 0.43 in Q1 2026 per CORZ's latest filing, down from 0.41 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.42 in Q1 2022 and bottomed at 1.78 in Q2 2024.
  • Median Equity Ratio over the past 5 years was 0.52 (2023), compared with a mean of 0.49.
  • The largest annual shift saw Equity Ratio soared 135.38% in 2022 before it plummeted 1241.14% in 2023.
  • Over 5 years, Equity Ratio stood at 0.51 in 2022, then crashed by 65.39% to 0.84 in 2023, then increased by 23.77% to 0.64 in 2024, then soared by 35.82% to 0.41 in 2025, then dropped by 3.73% to 0.43 in 2026.
  • Business Quant data shows Equity Ratio for CORZ at 0.43 in Q1 2026, 0.41 in Q4 2025, and 0.58 in Q3 2025.